The quest for an effective Alzheimer's treatment continues as recent trials of solanezumab, a monoclonal antibody targeting monomeric amyloid, yield disappointing results in slowing cognitive decline. Original Article:
State of Health Podcast:
Join this channel to get access to perks:
source
Detecting the early signs of Alzheimer’s is crucial because it allows for early intervention, which can help protect brain function and slow the progression...
Lithium, long used in psychiatry, is being repurposed for its neuroprotective potential in Alzheimer’s disease. This video explores evidence showing how lithium may modulate...
Alzheimer merupakan salah satu jenis penyakit demensia atau kepikunan yang dialami oleh para lansia. Sekitar 60 – 70 persen dari kasus demensia merupakan tipe...
This webinar for professionals covers what happens when people with intellectual and developmental disabilities have dementia. The training gives an overview of the risk...
Did you know that 60-80% of dementia cases are caused by Alzheimer's? Dementia is a neurodegenerative disease that can cause memory loss, behavioral changes,...
Vascular dementia is the second-most common form of dementia and often develops after a stroke. Dr. Jason Hinman of UCLA explains how disrupted blood...
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For...